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Objective  
The objective of this work was to develop and validate a method for multi-class, 
multiresidue determination of the series of Penicillins (Amoxycillin, Ampicillin, 
Cloxacillin, Dicloxacillin, Nafcillin, Oxacillin and PENG), Cephalosporins 
(Cefalexin, Cafalonium, Cefapirin, Cefaperazone, Cefquinome, Ceftiofur and  
Cefazolin) and Quinolones (Ciprofloxacin, Danofloxacin, Enrofloxacin, Flumequine 
and Marbofloxacin) regulated by European legislation 2377/90/EC in cow milk using 
LC-MS/MS.  
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Abstract 
The method was developed to determine simultaneously 19 drugs of three classes 
(seven Penicillins and Cephalosporins, and five Quinolones) regulated by European 
legislation 2377/90/EC in cow milk using LC-MS/MS. To make the sample 
preparation as simple as possible deproteinization step using organic solvent was 
eliminated. SPE clean up and concentration was done using OASIS HLB cartridge. 
The separation of 19 antibiotics was achieved in 11 minutes using C8 column with 
gradient elution. MS data was acquired on MRM mode with two transitions for each 
compound. Validation procedure was conducted based on European directive 
2002/657/EC. 89% of drugs presented recoveries higher than 65 % with exception of 
AMOX (57%) and DAN (38 %). Repeatability values expressed as relative standard 
deviation, (RSDs) were not more than 15 %. LODs values ranged from 0.03 (NAFC) 
to 0.5 µg/kg (PER) and LOQs from 0.1 (NAFC, PENG, CIP, DAN, and ENR) to 
1.25 µg/kg (PER). The method was applied to 49 real samples. 37% of the sample 
was found to be non-compliant with an error probability of ɴ. Of all samples 
analysed, 14 % of samples contained AMOX and 16 % contained PENG. AMOX 
and PENG was the most common residue found in milk sample. 
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1. Introduction  
Antibacterial agents also categorized as anti±infective, antimicrobials or 
chemotherapeutics comprise synthetic and natural compounds. The latter known as 
antibiotics are produced by fungi and bacteria at low concentrations for inhibiting 
growth of other microorganisms. Strictly antibiotics should include only five classes ± 
penicillins, tetracyclines, macrolides, aminoglycosides and Amphenicols. However 
currently the terms antibiotic is used synonymous with antibacterial, so synthetic drugs 
(e.g. quinolones or nitrofurans) and substances of high molecular weight (e.g. peptide 
antibiotics) also belong to this group [1]. 
1.1.  C lassification of Antibiotic 
On the basis of type of activity antibiotics can be divided into two groups:  
1.1.1 Bactericidal 
Antibiotics that cause bacterial cell death are called bactericidal. 
 ȕ-Lactams: ȕ- Lactams basically consists of two classes of thermally labile 
compounds, penicillins and cephalosporin. They are probably the most widely used 
class of antibiotics in veterinary medicine for the treatment of bacterial infections 
especially in lactating cows [2]. 
 Quinolones: Quinolones are synthetic broad spectrum antimicrobial agents used in 
the treatment of livestock and in aquaculture. They are used in veterinary medicine 
for the treatment of pulmonary infections, urinary infections and digestive infections 
in cows, pigs, turkeys or chicken [3-4]. 
 Aminoglycosides: In veterinary medicine and animal husbandry, they are widely 
used in the treatment of bacterial infections, e.g. bacterial enteritis and mastitis, and 
have been added to feeds for prophylaxis and to promote growth. They are currently 
not permitted for use as growth promoters in the European Union [5]. 
 Nitroimidazoles: Nitroimidazoles are a class of veterinary drugs used for the 
treatment and prevention of certain bacterial and protozoal diseases in poultry 
(histomoniasis in turkeys, trichomoniasis in pigeons etc) and for swine dysentery.  
Nitroimidazoles posses mutagenic, carcinogenic and toxic properties so have been 
prohibited in EU [3]. 
 Nitrofurans: Nitrofurans are antibacterial agents which have been widely used as 
feed additives for the treatment of gastrointestinal infections (bacterial enteritis 
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6 
caused by Escherichia coli and salmonella) in cattle, pigs and poultry.  Use of 
nitrofuran antimicrobials in food producing animals have been prohibited within EU 
since 1997 since they have been reported to be carcinogenic and mutagenic [3].  
1.1.2  Bacteriostatic 
Antibiotics that stops bacteria growth and allow host's normal defense mechanisms to 
combat the infection are bacteriostatic. Antibiotics that are predominantly bacteriostatic 
include the tetracyclines, the macrolides, chloramphenicol and trimethoprim.  
 Tetracyclines: Tetracyclines are broad spectrum antibiotics effective against gram 
positive as well as gram negative bacteria. They are used for promoting growth in 
cattle and poultry [3]. 
 Sulphonamides and T rimethoprim: They exhibit a bacteriostatic rather than 
bactericidal effect. Sulphonamides are used as veterinary drugs for prophylactic and 
therapeutic purposes; they also act as growth promoting substances [3]. 
 M acrolides: They are derived from Streptomyces bacteria, and got their name due to 
their macrocyclic lactone chemical structure. Macrolides are an important class of 
antibiotics which are widely used in veterinary practice to treat respiratory diseases 
or as feed additives to promote growth [3].   
 Amphenicols: They are synthetic antibiotics with similar broad-spectrum of activity. 
The Amphenicols class of antibiotics consists of chloramphenicol, thiamphenicol and 
florfenicol [6].Chloramphenicol is a broad spectrum antibiotic active against a 
variety of pathogen. It was previously used in veterinary and human medicine, 
however reports of plastic anemia in humans arising from its use led to its ban in the 
US and EU in 1994 [3]. The use of nitrofurans and chloramphenicol is not allowed in 
EU and therefore these compounds are classified in group A, the forbidden 
substances group [7]. 
1.2.  Mechanism of Action of Antibiotics  
The mechanism of action of antibiotics falls into following categories [6].  
1.2.1  Antimicrobials which can act on the Bacterial Cell Wall 
These interfere with synthesis of peptidoglycan layer in cell wall; they eventually cause 
cell lysis, bind to and inhibit activity of enzymes responsible for peptidoglycan 
synthesis. They interfere with cell wall synthesis by binding to penicillin binding 
proteins (PBPs), which are located in bDFWHULDOFHOOZDOOV(Jȕ-Lactams) 
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1.2.2 Antimicrobials acting on Nucleic Acid Synthesis  
 Inhibitor of RNA synthesis and function: These antimicrobials bind to DNA-
dependent RNA polymerase and inhibit initiation of RNA synthesis. They inhibit 
transcription. (E.g. Rifampin, rifampicin) 
 Inhibitor of DNA replication: They inhibit bacterial topoisomerase which are 
necessary for DNA synthesis. (E.g. nalidixic acid, ciprofloxacin)  
 Inhibitors of precursor synthesis: They inhibit early stages of folate synthesis. (E.g. 
sulphonamides)  
1.2.3  Antimicrobials acting on Protein Synthesis 
Antimicrobials acting on protein can be classified into those bind to 30S ribosome and 
50s ribosome subunit. 
Antimicrobials that bind to the 30S Ribosomal Subunit  
 Aminoglycosides: The aminoglycosides irreversibly bind to the 30S ribosome and 
freeze the 30S initiation complex (30S-mRNA-tRNA), so that no further initiation 
can occur. The aminoglycosides also slow down protein synthesis that has already 
initiated and induce misreading of the mRNA. 
 Tetracyclines: The tetracyclines reversibly bind to the 30S ribosome and inhibit 
binding of aminoacyl-t-RNA to the acceptor site on the 70S ribosome. 
 Spectinomycin: Spectinomycin reversibly interferes with mRNA interaction with 
the 30S ribosome. It is structurally similar to aminoglycosides but does not cause 
misreading of mRNA. 
Antimicrobials that bind to the 50S Ribosomal Subunit  
 Chloramphenicol, lincomycin, clindamycin: These antimicrobials bind to the 50S 
ribosome and inhibit peptidyl transferase activity. 
 M acrolides: The macrolides inhibit translocation of the peptidyl tRNA from the A to 
the P site on the ribosome by binding to the 50S ribosomal 23S RNA. E.g. 
erythromycin, azithromycin, clarithromycin 
1.2.4  Inhibitors of Bacterial Folate Synthesis 
These block cell metabolism by inhibiting enzymes which are needed in the 
biosynthesis of folic acid which is a necessary cell compound. 
 Sulphonamides, sulfones: These antimicrobials are analogues of para-aminobenzoic 
acid and competitively inhibit formation of dihydropteric acid. 
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 T rimethoprim, methotrexate, pyrimethamine :  These antimicrobials bind to 
dihydrofolate reductase and inhibit formation of tetrahydrofolic acid. 
1.2.5  Antimicrobials acting on the Cell Membrane 
 Amphotericin that binds to the sterol-containing membranes of fungi, 
 Polymyxins that act like detergents and disrupt the Gram negative outer membrane 
and 
 Fluconazole and itraconazole that interfere with the biosynthesis of sterol in fungi.  
 
                The diverse sites of action of antibiotics are summarized in figure 1.1. 
 
Figure (1.1): Action Sites of Antibiotics 
1.3 Antibiotic Resistance Mechanism 
Bacteria may manifest resistance to antibacterial drugs through a variety of 
mechanisms. Some species of bacteria are innately resistant to ш 1 class of antimicrobial 
agent. Other cases are acquired resistance. Acquired resistance that develops due to 
chromosomal mutations and selection is called vertical evolution. Bacteria also develop 
resistance through the acquisition of new genetic material from other organisms. This is 
termed as horizontal evolution. A resistance mutation can be expressed in several ways 
[8-9]. 
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1.3.1 Production of Enzyme that destroys Active Drug  
The first central mechanism by which bacteria can be resistant to an antibiotic is by 
production of enzymes that inactivate antimicrobials. The organism may acquire genes 
encoding enzymes such as ɴ-lactamases that destroy the antibacterial agent from the cell 
before it can reach its target site and exert its effect.  
1.3.2  Mutations in E fflux Mechanisms 
Antibiotic efflux pumps are a common way for bacteria to resist the action of numerous 
classes of antibiotics. Bacteria may acquire efflux pumps that extrude the antibacterial 
agent from the cell before it can reach its target site and exert its effect. They are chiefly 
concerned with removal of waste products, but changes in their conformation can 
enable them to remove antimicrobials. Gram positive organisms can show resistance to 
macrolides by this mechanism and resistance to tetracyclines is usually mediated via 
efflux. 
1.3.3 Bypass of Metabolic Pathway 
Bacteria may acquire several genes for a metabolic pathway which ultimately produces 
altered bacterial cell walls that no longer contain the binding site of the antimicrobial 
agent, or bacteria may acquire mutations that limit access of antimicrobial agents to the 
intracellular target site via down regulation of porin genes. Resistance to sulfonamides 
and trimethoprim is mediated by metabolic bypass, in this case due to synthesis of 
altered dihydropteroate synthetase and dihydropteroate reductase. These enzymes have 
reduced susceptibility and affinity for sulfonamides and trimethoprim respectively.  
O ther mechanism of resistance may occur through one of several genetic mechanism 
including transformation, conjugation and transduction. 
The most important vehicles for transfer of resistance genes in bacteria are plasmids, 
transposons and integrons.  
Plasmids: Plasmids are extra chromosomal, replicable circular DNA molecules that 
may contain resistance genes. They replicate independently of bacterial chromosomal 
DNA. Plasmids are important in bacterial evolution, because they affect replication, 
metabolism, bacterial fertility as well as resistance to bacterial toxins, antibiotics and 
bacteriophages. 
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T ransposons: Transposons (jumping genes) are short sequence of DNA that can move 
between plasmids, between a plasmid and the bacterial chromosome or between a 
plasmid and a bacteriophage (bacterial virus). Unlike plasmids transposons are not able 
to replicate independently and must be maintained within a functional replicon (plasmid 
or chromosome). 
Integrons and Gene Cassettes: Integrons are naturally occurring gene expression 
elements. They are composed of two conserved regions and an interposed variable 
region, which contains gene cassettes for antibiotic resistance.  
Some of the many mechanisms of resistance are indicated schematically in the figure 
1.2 
 
 
 
 
 
 
 
Figure (1.2): Mechanism of antibiotic resistance 
1.4.  Use of Veterinary Antibiotics in Dairy Cows 
$QWLELRWLF XVH LQ OLYHVWRFN SURGXFWLRQ RULJLQDWHG LQ WKH ¶V ZKHQ ZDVWH IURP WKH
fermentation process used in commercial chlortetracycline production was found to 
improve the growth rates of pigs, poultry, and cattle [10]. 
The use of antibiotics in veterinary medicine and especially in dairy cows involves [6] 
1.4.1. Therapeutic use to treat infected animals against diseases e. g. mastitis of dairy 
cows, diarrhoea, pulmonary diseases, bacteremia, etc. 
1.4.2. Prophylactic use to avoid infection of rest animals, preventing diseases. In dairy 
cows, antibiotics are routinely administered directly into the udder to cure and 
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avoid mastitis (e. g. in dry-cow therapy). The same therapeutic antibiotics are 
delivered directly into the fodder or drinking water. 
1.4.3. Use at sub-therapeutic levels to induce growth promotion. 
1.5.  Antibiotic Resistance associated with Therapeutic use of Veterinary Medicine  
Antimicrobials use will lead to the selection of resistant forms of bacteria which occurs 
with all uses including treatment, prophylaxis and growth promotion. Adverse 
consequences of selecting resistant bacteria in animals include:  
1.5.1.  An increase in the prevalence of resistant bacteria in animals, the transfer of 
resistant pathogens to humans via direct contact with animals or through the 
consumption of contaminated food and water, 
1.5.2.  The transfer of resistance genes to human bacteria, 
1.5.3.  An increase in the incidence of human infections caused by resistant pathogens, 
1.5.4.  Potential therapeutic failures in animals and humans.  Few examples associated 
with resistance mechanisms are:  
Fluoroquinolones use in poultry has given a dramatic rise in the prevalence of 
fluoroquinolones-resistant Campylobacter jejuni isolated in live poultry, poultry 
meat and from infected humans. Multi resistant Escherichia coli have been 
selected by the use of broad spectrum antimicrobials in both livestock and 
humans. 
1.5.5.  Residues of antimicrobial agents in food of animal origin in excess of the agreed 
acceptable minimum residue level (MRLs) may contribute to the generation of 
resistance in bacteria in humans [11]. 
1.6 Importance of determination of Antibiotic Residue 
Residue analysis is concerned with food safety, as it establishes whether food is safe or 
unsafe for human consumption. Incorrect use of antibiotics in veterinary practice may 
leave residues in edible tissues. These residues may have direct toxic effects on 
consumer e.g. antibiotics such as penicillin can evoke allergic reactions in 
hypersensitive individuals even though small amount are ingested or exposed by 
parental routes. Or they may cause problems indirectly through induction of resistant 
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strains of bacteria. As a result the antibiotic resistant pathogens do not respond well to 
therapy by ordinary antibiotics as a result new antibiotics must be developed [3, 10]. 
1.7 ȕ- Lactam Antibiotics  
ȕ-Lactam antibiotics comprise several classes of compounds such as penicillins, 
cephalosporins, and carbapenems, monobactams among which the penicillin and the 
FHSKDORVSRULQDUHPRVWLPSRUWDQW7KHVHFRPSRXQGVFRQWDLQWKUHHPDLQSDUWVȕ-lactam 
ring, free carboxyl acid group and a substituted amino acid side chain. Both penicillin 
DQGFHSKDORVSRULQKDYHDȕ-lactam ring but in the case of penicillin it is fused to a five 
membered thiazolidine ring, and in the case of cephalosporin it is fused to a six 
membered dihydrothiazine ring. 
 
 
 
 
 
Figure (1.3): Structure of penicillin and cephalosporin 
1.7.1.  Penicillins 
7KHSHQLFLOOLQVDUHFODVVLILHGDVȕ-lactam drugs because of their unique four-membered 
lactam ring. They share features of chemistry, mechanism of action, pharmacologic and 
clinical effects, and immunologic characteristicVZLWKRWKHUȕ-lactam compounds [12]. 
They are compounds with limited stability because of the presence of the four term ring 
in their structure and they are thermolabile, unstable in alcohols and isomerize in acid 
ambient [2]. 
Chemistry 
All penicillins have the basic structure shown in figure 1.4. A thiazolidine ring (A) is 
DWWDFKHG WR D ȕ-lactam ring (B) that carries a secondary amino group (RNH±). 
Substituent - R can be attached to the amino group. Structural integrity of the 6 
aminopenicillanic acid nucleus is essential for the biologic activity of these compounds. 
,I WKH ȕ-ODFWDP ULQJ LV HQ]\PDWLFDOO\ FOHDYHG E\ EDFWHULDO ȕ-lactamases, the resulting 
product, penicilloic acid, lacks antibacterial activity. The penicillins are susceptible to 
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bacterial metabolism and inactivation by amidases and lactamases at the points shown 
below[12].  
 
Figure (1.4): Basic structure of penicillin (6-aminopenicillanic acid) 
1.7.2.  Cephalosporins  
Cephalosporin is similar to penicillins chemically, in mechanism of action, and in 
toxicity. Cephalosporins are more stable than penicillins to many bacterial -lactamases 
and therefore usually have a broader spectrum of activity. The cephalosporins are 
bactericidal and inhibit the third stage of bacterial cell wall synthesis by interfering with 
cross-linking of linear peptidoglycan strands [13]. 
Chemistry 
The nucleus of the cephalosporins, 7-aminocephalosporanic acid (Figure 1.5), bears a 
close resemblance to 6-aminopenicillanic acid (Figure 1.4). The intrinsic antimicrobial 
activity of natural cephalosporins is low, but the attachment of various R1 and R2 
groups has yielded drugs of good therapeutic activity and low toxicity. The 
cephalosporins have molecular weights of 400±450. They are soluble in water and 
relatively stable to pH and temperature changes [12]. 
 
Figure (1.5): Structure of Cephalosporin 
1.8     Quinolones 
Quinolone are broad spectrum synthetic antimicrobial agent used in the treatment of 
livestock and aquaculture. The older quinolones e.g. nalidixic acid have limited activity 
against gram negative organisms while the more recently introduced fluoroquinolones 
e.g. Enrofloxacin have a wide spectrum of activity . In general Quinolone carboxylic 
acids are amphoteric with poor water solubility between pH 6 and 8 [13]. 
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Chemistry 
The general structure consists of quinolones consists of a 1-substituted-1, 4-dihydro-4-
oxopyridine-3-caboxylic moiety combined with an aromatic or heteroaromatic ring .The 
carboxylic acid at position 3 and the ketone group at position 4 are necessary for DNA 
gyrase inhibition, where as substitution at position 1 and 7 influence the potency and the 
biological spectrum of activity of the drugs [4]. 
 
Figure (1.6): Basic structure for Quinolone 
Due to the presence of carboxylic acid (pka §  DQG RQH RU PRUH DPLQH IXQFWLRQDO
groups (pka §-9), quinolones have amphoteric and zwitterionic properties; between pH 
6 and 8, they exhibit poor water solubility, but are lipid soluble and able to penetrate 
tissues [41].  
Mechanism of Action:  
Quinolones block bacterial DNA synthesis by inhibiting bacterial topoisomerase II 
(DNA gyrase) and topoisomerase IV. Inhibition of DNA gyrase prevents the relaxation 
of positively super coiled DNA that is required for normal transcription and replication 
[12]. 
1.9    Multiclass, M ulti Residue determination of Antibiotic in Food Samples 
Multiclass, multi residue methods are gaining importance for residue control in food 
products.  These methods are limited in comparision to single class residual methods 
not because that they are not needed, but because of a number of analytical challenges 
which have to be overcome. The first multi-class method for veterinary drugs residue in 
food products was reported by Yamada et.al in 2006 [14].  
Form the literature review [45] we can see that multi-class, multiresidue analysis is 
performed in two different ways. 
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 Qualitative [18] or quantitative screening assays [25], 
¾ Screening and confirmation [15, 19, and 21],  
¾ Screening and quantification [26]. 
 Quantitative confirmatory  
Table 1.1 provides a summary of recent chromatographic methods for detection of 
multiclass, multi residue analysis of antibiotics in wide range of sample matrices such 
as animal tissue, liver, kidney, egg, milk and honey.  
The articles [15, 22-23, 32-33, 35-36] are based on determination of multi-class, multi 
residue of antibiotics in milk samples. Some papers [14, 22] include validation data but 
do not fully comply with the EU commission decision 2002/657/EC. 
From the table 1.1, we can see that most of the papers utilizes Oasis HLB for clean up. 
However some papers eliminate the clean up in order to make the method fast and 
simple [24]. Some paper [33, 38, and 40] utilizes extraction procedure based on 
QuEChERS methodology. 
As can be seen from table 1.1, LC-MS/MS and UPLC-MS/MS are the common 
detection techniques for multi-class, multi residue analysis. 
This work involves development of method for Quantitative, confirmatory analysis of 
penicillins, cephalosporins and quinolones in milk using LC-MS/MS.  
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Table 1.1 Summaries of Existing Chromatographic Methodologies for Detection of Multiclass, M ulti Residue Analysis of Antibiotics  
 
No. of 
Residues 
Analyte M atrix 
Ext raction 
Technique 
C lean up Recovery (%) 
Detection 
System 
Application 
Date 
[Ref] 
130 Many Bovine, Porcine, 
Chicken Muscle 
ACN: 
MeOH(95:5) 
----- 70-110% LC-MS/MS Quantitation 2006 
[14] 
 
25 ɴLCs,SAs,Qs,MCs Milk Acetonitrile SPE  
(Oasis HLB) 
Low for ɴ-­‐LCs, 
MCs and Qs 
above 70%, TCs 
50-60% 
LC-MS/MS Screening, 
Confirmation 
2008 
[15] 
6 TCs, PCs Bovine and 
Swine, Muscle 
Kidney and Liver 
No No 70-115% LC ±MS/MS Screening 2005 
[16] 
18 TCs, SAs, Qs Shrimp Meat TCA SPE  
(Oasis HLB) 
         -------- LC-Ion trap Screening 
/Confirmatory 
2006 
[17] 
21 TCs, Qs Pig Kidney , 
Liver and meat 
EDTA-McIIvaine 
buffer 
SPE  
(Oasis HLB) 
80.2-117.8% UPLC-
MS/MS 
Screening, 
Confirmatory 
2007 
[19] 
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19 TCs, SAs, Qs, 
ȕ-LCs, MCs 
Muscle (Pig , 
Cattle, Sheep, 
Horse, Deer , 
Reindeer) Kidney 
(Pig , Cattle, 
Sheep, Horse) 
70 % Methanol --------- -------- 
 
LC-MS/MS Screening , 
Confirmation 
2007 
[20] 
29 SAs, TCs, FQs,    
ȕ-LCs 
Eggs ---------- SPE 
(Oasis HLB) 
--------- LC-MS/MS Screening , 
confirmation 
200 
[21] 
150 AVs,BZs,ɴagonist, 
ɴ-LCs, Cs, NZs, 
Qs, SAs, TCs 
Milk ACN -------- No UPLC-TOF-
MS 
Screening 2007 
[22] 
10 PLs , TCs, Cs Milk Methanol, 
MCIlvaine Buffer 
SPE 
(Oasis HLB) 
52.1% -101.0% 
 
UPLC Quantification 
 
2009 
[23] 
39 TCs, Qs, PCs, SAs  
,TMP,MCs 
Chicken Muscle MeOH:H2O(70:30) 
Containing EDTA 
No clean up 60-96.5% UPLC-
MS/MS 
Quantification, 
Confirmation 
2008 
[24] 
 
100 BZs, CH,DV, 
LI,MCs, NZs,PCs, 
SAs,TCs, Ts 
Muscle , Liver , 
Kidney 
Liquid ± Liquid 
Extraction 
SPE  
(Oasis HLB) 
Muscle:14-118% 
Liver:16- 121% 
Kidney:13-141% 
UPLC-TOF Quantitative 
2008 
[25] 
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100 BZs,MCs,PCs,Qs, 
SAs,PYs,TCs,NZs
, Ts,Ns,Is,As, 
Milk ACN SPE 
(Strata- X) 
80-120% UPLC-TOF-
MS 
Screening, 
Quantification, 
Confirmation 
2008  
[26] 
15 PCs ,Cs Bovine Muscle, 
Kidney and Milk 
ACN/Water SPE 
(Oasis HLB) 
Milk : 57-115% 
Muscle:65-111% 
Kidney:46-90% 
LC-MS-MS Screening / 
Quantification/ 
Confirmation 
2004 
[28] 
47 
TCs,Qs,MCs ,SAs 
,DPs ,LCs  
Milk 
TCA, MCIlvaine 
buffer 
SPE  
Oasis HLB 
94-112% LC-MS/MS 
 
Quantification 
 
2009 
[32] 
18 
Qs, SAs, MCs, 
 As, TCs 
Milk 
Liquid Extraction 
with ACN 
No cleanup 70-110% 
UPLC ±
MS/MS 
Quantification, 
Confirmation 
2008 
[33] 
 
19 
TCs, SAs, TMP,  
Ds 
Muscle (Bovine, 
Ovine, Porcine 
and Poultry) 
0.1M EDTA and 
ACN 
No SPE 
clean up 
94-102.1% 
UPLC ±
MS/MS 
Quantification 
Confirmation 
2009 
[34] 
7 TCs, SAs ,CPs Bovine Milk TCA 
SPE  
(Oasis HLB) 
83-112% HPLC-DAD Quantitative 
2009 
[35] 
 
 
European Masters in Quality in Analytical Laboratories 
 
 
10 SAs, TCs, Ps Cow Milk 
TCA, MCIlvain 
buffer 
SPE  
(Oasis HLB) 
72-97% HPLC-MS Quantitative 
2007 
[36] 
8 FQs, TCs Catfish muscle 
ACN and Citrate 
Buffer 
----- 60-92% 
LC±
Fluorescence 
Quantitation 
2007  
[37] 
 
25 
TCs, MCs, Qs,  
SAs, As 
Eggs 
ACN+Citric 
acid+Na2EDTA 
QuEChERS 60-119% 
UPLC ±
MS/MS 
Quantitation 
2009 
[38] 
15 
TCs , FQs , MCs , 
LCs ,AGs , SAs, 
PLs 
Honey ------- 
SPE (Strata 
X 60mg, 
3ml) 
65-104% LC-MS/MS 
Quantification 
,Confirmation 
2008 
[39] 
41 
NZs, SAs, FQs, 
Qs, Is  
Chicken muscle  QuEChERS 
Dispersive 
SPE  
Varies  LC-MS/MS Screening  
2009 
[40] 
 
Acronyms: PCs: Penicillins , Cs : Cephalosporins, TCs : Tetracyclines , Qs : Quinolones, MCs: Macrolides, SAs: Sulfonamides, 
DPs:diaminopyrimidine , LCs: Lincosamides, PLs : Phenicol , TMP: Trimethoprim, Ps: Pyrimethamine, Ts : tranquilizers , As : Antihelminthes , 
PYs : Pyrimidine, NZs: Nitroimidazoline,  CAP: chloramphenicol , Ds: dapsone , Ns : NSAIDS, AVs: avermectin , COs: corticoids, Is: 
Ionophores, As: Amphenicols, ȕ-/&Vȕ-Lactams, FQs: Fluoroquinolones, AGs: Aminoglycosides 
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1.10 European Regulation for the Use of Veterinary Drugs 
In EU the use of veterinary drugs is regulated through council regulations 
2377/90/EC. This regulation describes the procedure for the establishment of 
maximum residue limits (MRLs) for veterinary medicinal products in foodstuffs of 
animal origin. The primary consumer safety consideration is addressed through 
Maximum Residue Limits (MRL). The MRL defines the maximum level of residues 
of any component of a veterinary medicine that may be present in foodstuffs of 
animal origin without presenting any harm to the consumer [28]. MRLs are fixed at 
the mg/kg level (part per million) or even at the µg/kg level (parts per billion). 
Residues below MRL are considered safe and samples are considered non compliant 
[6]. 
The council regulation 2377/90/EC has established lists of compounds that have a 
fixed MRL (Annex I), that need no MRL (Annex II) or which have a provisional 
MRL (Annex III). According to directive 96/23/EC, ɴ-lactam and quinolones belong 
to group B, and the MRL values for these compounds milk have been established and 
are shown in Tables 1.2, 1.3 and 1.4 for bovine tissues and milk. 
 
 
  
 
 
 
 
 
 
Regulation (EEC) no 
2377/90 
Directive 96/23/EC 
Decision 2002/657/EC 
Establishes maximum residue limits of 
veterinary medicinal product in food 
stuffs of animal origin. 
 
Regulates residue control of 
pharmacologic compounds, dyes, 
chemical elements in products of animal 
origin. Divides residues into group A , 
group B . 
Implementing council directive 96/23/EC 
concerning the performance of analytical 
methods and the interpretation.  
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Table: 1.2. L ist of Penicillins that are regulated by E U in M ilk 
 
Name and Chemical Structure Animal Species M R L 
Target 
T issue 
Amoxycillin (AMOX) 
O
H
N
N
O
S
COOH
CH3
CH3
OH
NH2
 
All food 
producing species 
50 µg/kg 
50 µg/kg 
50 µg/kg 
50 µg/kg 
4 µg/kg 
Muscle 
Fat 
Liver 
Kidney 
M ilk 
Ampicillin (AMPI) 
O
H
N
N
O
S
COOH
CH3
CH3
NH2
 
All food 
producing species 
50 µg/kg 
50 µg/kg 
50 µg/kg 
50 µg/kg 
4 µg/kg 
Muscle 
Fat 
Liver 
Kidney 
M ilk 
Benzylpenicillin (PEN G) 
 
All food 
producing species 
 
50 µg/kg 
50 µg/kg 
50 µg/kg 
50 µg/kg 
4 µg/kg 
Muscle 
Fat 
Liver 
Kidney 
M ilk 
Cloxacillin (CLOX) 
N
O
N
H
O
CH3
N
O
S CH3
CH3
COOH
Cl
 
All food 
producing species 
 
300 µg/kg 
300 µg/kg 
300 µg/kg 
300 µg/kg 
30 µg/kg 
Muscle 
Fat 
Liver 
Kidney 
M ilk 
Dicloxacillin (DICL) 
N
O
N
H
O
CH3
N
O
S CH3
CH3
COOH
Cl
Cl
 
All food 
producing species 
 
300 µg/kg 
300 µg/kg 
300 µg/kg 
300 µg/kg 
30 µg/kg 
Muscle 
Fat 
Liver 
Kidney 
M ilk 
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Nafcillin (NAFC) 
N
H
O
N
O
S CH3
CH3
COOH
OC2H5  
All ruminants 
 
300 µg/kg 
300 µg/kg 
300 µg/kg 
300 µg/kg 
30 µg/kg 
Muscle 
Fat 
Liver 
Kidney 
M ilk 
Oxacillin (OXAC) 
N
O
N
H
O
CH3
N
O
S CH3
CH3
COOH  
All food 
producing species 
 
300 µg/kg 
300 µg/kg 
300 µg/kg 
300 µg/kg 
30 µg/kg 
Muscle 
Fat 
Liver 
Kidney 
M ilk 
 
Table: 1.3. L ist of Cephalosporins that are regulated by E U in milk  
 
Name and Chemical Structure Animal species M R L Target tissue 
Cefalexin (LEX) 
 
Bovine 
200 µg/kg 
200 µg/kg 
200 µg/kg 
1000µg/kg 
100µg/kg 
Muscle 
Fat 
Liver 
Kidney 
M ilk 
Cefalonium (LON) 
 
Bovine 20µg/kg M ilk 
Cefapirin (PIR) 
 
Bovine 
50 µg/kg 
50 µg/kg 
100µg/kg 
60 µg/kg 
Muscle 
Fat 
Kidney 
M ilk 
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Cefazolin (ZOL) 
 
Bovine , ovine , 
caprine 
50 µg/kg M ilk 
Cefaperazone (PER) 
 
Bovine 
 
50 µg/kg 
 
 
M ilk 
 
Cefquinome (QUI) 
 
Bovine 
50 µg/kg 
50 µg/kg 
100µg/kg 
200µg/kg 
20 µg/kg 
 
Muscle 
Fat 
Liver 
Kidney 
M ilk 
 
Ceftiofur (TIO) 
 
All mammalian 
food producing 
species 
 
1000 µg/kg 
2000 µg/kg 
2000 µg/kg 
6000 µg/kg 
100 µg/kg 
Muscle 
Fat 
Liver 
Kidney 
M ilk 
Table: 1.4. L ist of Quinolones that are regulated by E U in milk  
Name and Chemical Structure Animal species M R L Target 
tissue 
Danofloxacin (DAN) 
Bovine, ovine, 
caprine 
 
200 µg/kg 
100 µg/kg 
400 µg/kg 
400 µg/kg 
Muscle 
Fat 
Liver 
Kidney 
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30 µg/kg M ilk 
Sum of : 
Enrofloxacin (ENR) 
 
Ciprofloxacin (CIP) 
 
Bovine , ovine , 
caprine 
 
100 µg/kg 
100 µg/kg 
300 µg/kg 
200µg/kg 
100 µg/kg 
 
Muscle 
Fat 
Liver 
Kidney 
M ilk 
 
Flumequine (FLU) 
 
Bovine ,Porcine 
Ovine , Caprine 
200 µg/kg 
300 µg/kg 
500 µg/kg 
1500 µg/kg 
50 µg/kg 
 
Muscle 
Fat 
Liver 
Kidney 
M ilk 
 
Marbofloxacin (MAR) 
 
Bovine 
 
150 µg/kg 
50 µg/kg 
150µg/kg 
150µg/kg 
75 µg/kg 
 
Muscle 
Fat 
Liver 
Kidney 
M ilk 
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Figure 1.7 and 1.8 shows the chemical structure for internal standard 
 
 
 
 
 
Figure (1.7): PIPE (Piperacillin) 
                                          Figure (1.7)PIPE (Piperacillin) 
 
  
   
 
 
 
Figure (1.8) PIP (Pipemidic acid) 
The determination of single class of antibiotics has been carried out previously in our 
research group [29-31]. This method involves combination of these works for 
simultaneous determination of penicillins, cephalosporins and quinolones in milk 
samples by LC-MS/MS. 
The work begins with preliminary study to choose the type of milk to develop the 
method. After selection of type of milk further a comparative study was done for 
optimization of extraction method for better recovery of analytes.  We have then 
proceeded to validation of the method according to European commission decision 
2002/657/EC and some parameters from FDA guidelines using raw milk.  Finally the 
method was applied for real samples (positive milk samples) supplied by Laboratori 
Interprofessional Lleter de Catalunya (ALLIC).    
N
S
HOOC   H
O
CONHCHH2NCONHN
OO
CH3CH2
CH3
CH3
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Exper imental 
2.1  Reagents and M aterials 
2.1.1. Standards 
 7KH SHQLFLOOLQ¶V VWDQGDUGV $PSLFLOOLQ $03, 'LFOR[DFLOOLQ ',&/
Benzylpenicillin (PENG) were supplied by the European pharmacopeia 
(Strasbourg Cedex, France), Amoxycillin (AMOX), Nafcillin(NAFC) and 
Oxacillin (OXAC) were obtained from Sigma-Aldrich (St. Louis, MO, USA), and 
Cloxacillin (CLOX) were obtained from Fluka (Buchs, Switzerland). 
 The cephalosporin standard Cephalexin (LEX),Cefalonium ( LON), Cefapirin 
(PIR), Cefazolin (ZOL) and Cefoperazone (PER) were obtained from Sigma 
Aldrich, Cefquinome (QUI) from A.K Scientific, and Ceftiofur (TIO) from 
Riedel-de Haën. 
 The Quinolone standard Danofloxacin (DAN) were purchased from Pfizer            
(Karlsruhe, Germany) , Enrofloxacin (ENR) (Cenavisa Reus, Spain) , Flumequine 
(FLU), Marbofloxacin (MAR), Ciprofloxacin (CIP) from (Sigma, St. Louis 
,MO,USA), 
 The internal standard Piperacillin (PIPE) and Pipemidic acid (PIP) were obtained 
from Fluka (Buchs, Switzerland) and (Prodesfarma) respectively.   
2.1.2. Reagent and Solvent  
 All reagents were LC grade. Methanol, MeOH (99.9%), Acetonitrile, ACN 
(99.9%), Formic acid, HFO (98%), Acetic acid (glacial), HAC 99.9 % were 
obtained from Merck, Darmstadt, Germany. 
 :DWHU RI /& JUDGH ZLWK UHVLVWLYLW\  0ȍFP ZDV obtained using a water 
purifier Purelab plus.  
 Sodium dihydrogen phosphate, NaH2PO4 > 99.0 % was obtained from Merck 
Darmstadt, Germany. 
 2.1.3 Preparation of Standard and Stock Solutions 
 Individual Stock Solutions: Stock standard solution of each antibiotics were 
prepared at a concentration of 100 ppm by dissolving the quantity of each 
compound (AMOX, AMPI, PENG, CLOX, DICL, NAFC, OXAC, LEX, LON, 
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PER, QUI, TIO, ZOL and PIR) in water, (CIP, DAN, ENR, and MAR) in 50 Mm 
acetic acid and FLU in acetonitrile. 
 Working Solutions: 100 MRL of the working standard mixture solutions used to 
spike the milk samples were prepared by mixing the individual solution and stored 
under refrigeration (-8°C) until use. These solutions were prepared separately for 
penicillins, cephalosporins and quinolones. 100 MRL solution was prepared in 
following way.20 MRL solution was prepared by diluting 100 MRL solution. 
 For penicillins 40µl of AMOX, AMPI, PENG and 300 µl of CLOX, DICL, 
OXAC and NAFC in 10 ml of water. 
 For cephalosporins 600µl of PIR, 200 µl of QUI, LON, 500 µl of ZOL, PER 
and 1000 µl of LEX and TIO in 10 ml of water.  
 For quinolones 300µl of DAN, 1000 µl of ENR and CIP, 500 µl of FLU and 
375 of MAR in 10 ml of water. 
 A solution of PIPE and PIP was prepared at concentration of 100 mg L-1 in water.  
 0.1M sodium dihydrogen phosphate solution at pH 10 was prepared by dissolving 
in water adjusting pH by 5M NaOH.  
2.1.4. Solid Phase Extraction Cartridge  
The solid phase extraction (SPE) cartridge used in this study was Oasis HLB (3 ml, 
60 mg) obtained from Waters, Milliford; USA. Oasis HLB is a macro porous 
copolymer consisting of two monomers, the lipophilic N-divinylbenzene and the 
hydrophilic N-vinylpyrrolidone. The hydrophilic N-vinylpyrrolidone increases the 
water wettability of the polymer and the lipophilic divinylbenzene provides the 
reversed phase retention necessary to retain analytes [3].  
The characteristics, properties and structure of the Oasis HLB sorbent are detailed in 
figure 2.1 and table 2.1. 
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Table: 2.1. Prope rties of Oasis H L B sorbent  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (2.1): Structure of Oasis HLB cartridge 
Oasis HLB cartridges was choosen for this experimental procedure because it allows 
to extract all kinds of antibiotics studied at the same time. From the literature review 
we can see that Oasis HLB has been successful in isolating residues of interest in 
milk [15,23,32,36] and also have been successfully utilized in many multiclass 
residue methods [17,19,21,25,27].It has proven to provide efficient extraction with 
optimal recovery, equal retention and also history of batch to batch reproducibility 
[25]. 
2.2  Inst rumentation 
 Technical balance from Sartorius laboratory (model LP2200P, sensitivity 0.01-
0.05g) was used to weigh the samples and NaH2PO4 buffer.  
 Specification 
Specific surface area ( m2/g) 727-889 
Average pore diameter (A° ) 73-89 
Total pore volume ( cm3/g) 1.18-1.44 
Average partic le diameter (µm) 25.0-35.0 
F ines content  
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 Analytical balance from Mettler Toledo (Model AB204, precision 0.1 mg) was 
used for weighing standards.  
 Selecta ultrasound system was used to dissolve the standard solutions. 
 The pH of the buffer and mobile phase was measured using Crison-micro pH 
2002 Potentiometer (± 0.1 mV) (Crison, Barcelona, Spain). A 5203 combinated 
pH electrode from Crison was used and the electrode was soaked in water when 
not in use.  
  A vortex mixer Heidolph, model Reax 2000 was used for samples agitation. 
 Supelco visidry 24  port was used for solid phase extraction  
 Additive Visidry desiccant, designed for the Supelco Visiprep vacuum distributor, 
using a stream of compressed nitrogen was used for sample evaporation.  
 Hettich Mikro 20 Mini centrifuge, to centrifuge the samples after being 
reconstructed  
2.2.1.  LC-MS/MS  
Chromatographic analysis was performed using a HP Agilent Technologies 1100 LC 
system equipped with an auto sampler. Separations were achieved using Zorbax 
Eclipse XDB-C8 (150 mm x 4.6 mm, 5µm particle size , Agilent Technologies) with 
a Kromasil C8 guard column (20 mm x 4.5 mm, Aplicaciones Analíticas).  
Mass spectrometry was performed on API 3000 triple quadrupole mass spectrometer 
(PE SCIEX) using turboionspray ionization in positive mode. Each transition was 
detected in MS/MS multiple reaction monitoring mode with 90ms dwell time.  
2.2.2. UPLC-MS/MS 
Chromatographic analysis was performed using Acquity ± Ultra Performance LC ± 
Waters system equipped with an auto sampler. The chromatographic separations 
were evaluated using two columns: Acquity UPLC BEH shield RP 18 (50 mm x 2.1 
mm, 1.7 µm particle diameter ) Waters, Ireland and Kinetex 2.6 U C18 100 A (150 x 
4.60 mm, Phenomenex, Kinetex ±USA). 
Mass spectrometry was performed on API 3000 triple quadrupole mass spectrometer 
(PE SCIEX) using turboionspray ionization in positive mode. 40 ms dwell time was 
used for each transition. 
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2.2.3. Data Process  
For both instruments, instrument control and data acquisition were performed with 
WKHKHOSRIWKHVRIWZDUH³$QDO\VW´YHUVLRQE\$SSOLHG%LRV\VWHP. 
2.3.  Experimental Procedure 
2.3.1. Milk Samples 
Different kinds of milk samples were analysed. Raw milk samples (not pasteurized) 
were used for method validation which was kindly supplied by Laboratori 
Interprofessional Lleter de Catalunya (ALLIC). The raw milk sample was stored in 
frozen state at -20°C until analysis. The commercial milk samples (whole milk) were 
obtained from local supermarket. Positive milk samples were obtained from different 
FRZVVSHFLPHQRUDOO\PHGLFDWHGZLWKȕ-Lactams antibiotics which were supplied by 
ALLIC. 
2.3.2. Sample Preparation 
Sample preparation is one of the critical steps for multiclass, multi residue 
determination of antibiotics in food sample because antibiotics with different 
physicochemical properties (pka, polarity, solubility) have to be determined 
simultaneously. To establish a suitable method for extraction of antibiotics from raw 
milk different extraction methods were applied represented in table 2.2. 
Table: 2.2 Nomenclature of Ext raction Procedure  
Method Ext raction Procedure Procedure 
1 E1 
 Weigh, 
 Spike with WS and IS  
 No centrifugation of the sample 
2 E2 
 Centrifuge the sample,  
 Weigh, 
 Spike with standards 
3 E3 
 Weigh,  
 Spike  
 Centrifuge the sample before 
passing through SPE cartridge 
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The steps of sample preparation are listed below:  
 2 g of milk was weighed into a polypropylene centrifuge tube in case of E1 and 
E3. However, in case of E2 the sample was centrifuge before weighing.  
 2 ml of Milli±Q water was added into individual test tubes.  
 The sample was spiked with working standard and internal standard. 
 0.5 ml of 0.1 M NaH2PO4 (pH 10) solution was added and the mixture was vortex 
for 40 seconds. 
 Conditioning of the sorbent: Before the sample was passed through the SPE 
cartridge it was precondition with 1 ml of MeOH, 1 ml of H2O and 1 ml of 
NaH2PO4 solution at pH10.  
 Application of sample to the sorbent: Retention of analyte and matrix occurs in 
sorbent.  In case of E2 the sample was centrifuge after addition of standards, 
before passing through SPE cartridge. Care was taken so that supernatant was 
transferred to cartridge avoiding any visible fat layer. Positive pressure was 
applied with the help of syringe when needed.  
 Rinsing the sorbent bed: After the sample is passed through the cartridge to 
decrease the matrix interference it was cleaned with 3 ml of water.  
 Elution of the retained compounds: In order to disrupt the analyte ± sorbent 
interaction, 2 ml of methanol was added and substances were eluted. 
 The eluate was evaporated to dryness by nitrogen stream and the residue was 
reconstituted with 200 µl of water.  
 The tube containing the extract was vortex for 1 min and was transferred to 
eppendorf which was centrifuged at 10000 rpm for 4 minutes and supernatant is 
stored in glass vials in freezer at -8°C until analysed by LC-MS/MS. 
 For UPLC-MS/MS analysis, samples were further filtered by using a Millipore 
ultra free -MC centrifugal filter device. (Centrifuge filter device, 0.22 µm filter 
unit) before injection. 
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General Steps involved in the use of SPE are represented schematically in the    
figure 2.2  
 
 
Figure (2.2): General SPE procedure 
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Flow chart diagram of the process is represented schematically in Fig 2.3  
 
 
 
 
 
 
 
         
                 
 
 
 
 
 
 
 
 
                               
                              Figure (2.3): Flow chart for extraction of Analyte                           
Sample Preparation 
 
SPE Clean Up + 
Concentration 
HPL C-MS/MS  UPL C-MS/MS  
 
Pass M ilk through 
Cartridge 
Wash with 3 ml of Water 
E lute with 2 ml of Methanol 
Nitrogen Drying 
Reconstitute with 200 µl of H 20 
Add 2ml of Water 
 
Spike with working 
standard & IS 
 
OASIS HLB 
Reduces viscosity, improves 
uniformity and loading of 
sample. 
To decrease the 
matrix interference 
Store the Supernatant 
Ensure Reproducible 
retention of Analytes. 
2 g of 
M ilk 
Add 0.5 ml of phosphate solution pH10 
   
V
or
te
x 
 
 1ml of MeoH 
1 ml of H2O 
1 ml of phosphate solution pH10 
 
 
SPE 
Conditioning 
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2.3.3. Chromatographic Condition 
2.3.3.1. LC-MS/MS  
Separation was performed on a gradient mode with mobile phase A consisting of 0.1 
% formic acid in H2O and mobile phase B consists of 0.1% formic acid in ACN. 
Both A and B contains 0.1 % formic acid as mobile phase additive. Addition of 
formic acid in mobile phase can change the pH value of mobile phase and affect the 
chromatographic separation. The flow rate was set at 1ml/min and the injection 
volume was 20µl.The total run time for each injection was 10 min. Table 2.3 shows 
the gradient used for the separation using LC-MS/MS system and E3 extraction 
method.  
Table 2.3 L C-MS/MS gradient  
 
 
  
 
 
 
 
Figure 2.4 shows the separation of antibiotics studied 
Time A(H2O) B(A C N) 
0 85 15 
2 85 15 
4 55 45 
7 44 56 
8.5 85 15 
11 85 15 
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XIC of +MRM (21 pairs): 335,0/160,0 amu from Sample 21 (RE_4_2_LC) of 27_10_09.wiff (Turbo Spray) Max. 1,5e5 cps.
1 2 3 4 5 6 7 8 9 10
Time, min
0,0
2,0e5
4,0e5
6,0e5
8,0e5
1,0e6
1,2e6
1,4e6
1,6e6
1,8e6
2,0e6
2,2e6
2,4e6
2,6e6
2,8e6
3,0e6
3,2e6
3,4e6
3,6e6
3,8e6
4,0e6
4,2e6
4,4e6
4,6e6
4,8e6
Intensity, cps
1
2
3 4
5
8 9  
10
11
12
13
14
15
16
17
18
19
20
21
6
7
 
Figure (2.4): Chromatogram obtained from a milk sample fortified to the 4MRL 
concentration using LC-MS/MS where 1)AMOX, 2) PIR, 3) QUI, 4) PIP, 5) MAR, 
6) AMPI, 7) LEX, 8) LON, 9) CIP, 10) DAN, 11)ENR,  12) ZOL, 13) PER, 14) 
TIO,15)PIPE 16 ) PENG 17 ) FLU 18) OXAC 19) CLOX 20) NAFC, and 21) DICL. 
 
2.3.3.2. UPLC-MS/MS System 
The mobile phase used for UPLC-MS/MS is similar to that used for LC-MS/MS as 
described in 2.3.3.1. Two columns were checked for the separation efficiency of 
analytes. Properties for packing for both column are given below.  
A) Acquity UPLC BEH (Bridged ethylsiloxane/silica hybrid particle) Shield RP 18  
The column chemistry is shown in figure 2.5 and the properties of the packing 
material of the column is described in table 2.4 
 
 
 
            Figure (2.5) ACQUITY UPLC BEH Shield RP 18 
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Table (2.4) Acquity UPL C B E H Chemist ry  
Bonded phase 
Ligand type  Monofunctional embedded polar group 
Ligand Density  3.3 µmol/m2 
Carbon Load  17% 
Endcap style  TMS 
pH range  2-12 
BEH Particle 
Pore Diameter 130϶A 
Pore Volume 0.7 mL/g 
Surface Area 185 m2/g 
 
b) Kinetex 2.6 µm Core-Shell Particle 
Kinetex core shell particle consists of porous shell and core shell. The material 
characteristics of Kinetex column is shown in table (2.5)  
 
                              Figure (2.6) Kinetex 2.6 µm Core-Shell Particle 
Table (2.5) K inetex 2.6 µm Core-Shell Partic le 
Total Particle size (µm) 2.6 
Porous Shell (µm) 0.35 
Solid core (µm) 1.9 
Pore Size (϶A) 100 
Effective surface area (m2/g) 200 
Effective carbon load % 12 
pH stability 1.5-10 
Pressure stability 600 bar 
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Initially the flow rate was set to 0.3ml/min for both columns but for Kinetex column 
peaks were overlapping so was changed to 1 ml/min. The injection volume was 6µl. 
Several gradient were studied, the better separation were obtained with the gradient 
showed in Table 2.4. 
Table 2.6 G radient for two columns 
Acquity K inetex 
T ime % A(A C N) % B (H20) T ime % A(A C N) % B (H20) 
0 15 85 0 20 80 
0.28 15 85 1.67 20 80 
0.74 45 55 3.06 50 50 
1.44 56 44 5.14 61 39 
1.78 56 44 6.18 61 39 
2.36 15 85 7.92 20 80 
3.5 15 85    
 
2.3.3.3. Optimization of the Operational Parameters of the Mass Spectrometer 
In a previous study [29-31] the MS conditions were optimized by direct infusion of 
each compound at a concentration of 10 mg/L at a flow rate of 0.005 ml min-1. In this 
study same potential was used to obtain the optimum parameters for each compound. 
The optimized potential used for each antibiotic in order to detect antibiotics with 
higher signals is shown in table 2.6.  
Declustering potential (DP): This is the potential applied to the orifice plate. This 
potential has the greatest effect on the amount of fragmentation of the ions in the 
orifice skimmer region of the source area. The declustering potential is the difference 
between the orifice voltage and the skimmer voltage. The higher the voltage the 
greater is the amount of declustering. The working range of the DP is typically 0 to 
100 V although it may be set as high as 200 V.  
Focussing potential (FP): The FP helps to focus the ions through the skimmer. It 
also effects the declustering of ions in the orifice ± skimmer region. The FP is 
difference between the voltage on the focussing ring and the skimmer voltage.  A 
typical value is 200- 300 V.  
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Entrance potential (EP): The EP is the difference between the voltage on the high 
pressure entrance quadrupole and the skimmer voltage. It is typically set at ± 10 V 
and affects selling of all other instrument voltage. 
Table 2.6 shows the optimal values of the potentials  
Table 2.7 Optimal values of the potentials  
 
Family Antibiotic DP FP EP 
Penicillins 
AMOX 40 150 6 
AMPI 65 150 6 
CLOX 40 140 7 
DICL 50 150 8 
OXAC 50 120 9 
NAFC 40 160 9 
PENG 65 220 7 
Cephalosporin 
LEX 30 125 5 
LON 30 125 5 
PIR 40 150 5 
PER 50 200 11 
QUI 40 175 5 
TIO 50 200 5 
ZOL 40 175 5 
Quinolones 
CIP 45 200 10 
DAN 45 200 10 
ENR 45 200 10 
FLU 38 200 10 
MAR 45 200 10 
IS 
PIP 50 200 10 
PIPE 40 175 5 
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The turboion spray was in positive mode with following settings:  
Ion spray voltage  
This is the voltage applied to the needle that ionizes and nebulises the sample. The 
ion spray voltage parameter depends on the polarity and affects the stability of the 
spray and sensitivity. The ion spray voltage used is 4500V.  
Nebuliser gas (NEB) 
This is the gas that focuses the spray in the nebuliser. The nebuliser gas parameter 
affects the stability of the spray and sensitivity. The Nebulizer gas used is 10 
arbitrary units. 
Curtain gas (CUR) 
This is the gas between the curtain plate and the orifice plate. The main function of 
the curtain gas is to prevent the contamination of the ions optics. The curtain gas 
depends on the solvent flow rate. The curtain gas used is 12 arbitrary units. 
Auxiliary Gas  
The nebuliser and auxiliary gas affects the stability of the spray and sensitivity. 
These gases have different names in different instruments. For turbo ion spray 
sources the auxiliary gas is the turbo (heater) gas. Auxiliary gas flow is 4500 
cm3/min and Auxiliary gas temperature is 400 º C. 
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Two MRM transitions were studied for each analyte. The most intense one was used for the quantification and the minor one for confirmation of 
the analyte. The quantification and identification transition that was optimized in a previous study [29-31] was applied in this study. 
European commission decision 2002/657/EC establishes identification (IPs) in order to confirm the residues of antibiotics in food stuffs of 
animal origin. For the confirmation of antibiotics studied (listed in group B of Annex I of directive 96/23/EC), a minimum of 4 IPs is required. 
With two transitions, 1 precursor and two daughter ions, we achieve total of 4 IPs using LC-MS/MS. 
Table 2.7 shows MS/MS transitions for quantification and confirmation as well as collision energy values optimized for each of the studied 
antibiotics. 
Table 2.8 MS/MS Parameters for the antibiotics studied  
 
Family Antibiotic HPL C * 
tR(min) 
UPL C#  
tR(min) 
Quantification 
T ransition 
Collision Energy 
(C E) 
Identification 
T ransition 
Collision Energy 
(C E) 
Penicillins 
AMOX 2.1 0.65 ĺ 28 ĺ 19 
AMPI 4.26 0.86 ĺ 26 ĺ 21 
CLOX 8.76 2 ĺ 20 ĺ 20 
DICL 9.75 2.21 ĺ 21 ĺ 22 
NAFC 8.94 2.05 ĺ 19 ĺ 21 
OXAC 8.23 1.89 ĺ 18 ĺ 18 
PENG 7.42 1.68 ĺ 16 ĺ 16 
European Masters in Quality in Analytical Laboratories 
 
 
Cephalosporins 
LEX 2.31 0.85 ĺ 35 ĺ 15 
LON 6.18 1.12 ĺ 30 ĺ 20 
PIR 4.38 0.68 ĺ 20 ĺ 35 
PER 6.49 1.43 ĺ 35 ĺ 20 
QUI 4.76 0.74 ĺ 20 ĺ 20 
TIO 5.73 1.45 ĺ 30 ĺ 25 
ZOL 2.61 1.34 ĺ 15 ĺ 25 
Quinolones 
CIP 5.19 1.08 ĺ 32 ĺ 27 
DAN 5.33 1.11 ĺ 31 ĺ 31 
ENR 5.5 1.14 ĺ 29 ĺ 29 
FLU 7.92 1.75 ĺ 26 ĺ 45 
MAR 4.22 0.88 ĺ 22 ĺ 30 
I .S. PIPE 2.85 1.54 ĺ 25 5ĺ 15 
PIP 6.88 0.71 ĺ 30 ĺ 25 
 
* Column used for separation is Zorbax Eclipse XDB-C8 (150mm x 4.6mm, Agilent Technologies) 
# Column used for separation is Acquity UPLC BEH shield RP 18. 
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3.  Results and Discussion 
3.1.  Preliminary Study 
3.1.1. Comparision between Raw and Commercial Milk 
Milk consists of fat which have a very different composition in raw and commercial 
milk. In order to optimize the extraction method a preliminary study was done using 
commercial whole milk (CM) and comparing the recoveries obtained with the raw 
milk (RM). In order to compare the behaviour of the antibiotics in both milk 
samples, the easier method i.e. E1 was applied as described in experimental section 
2.3.2. 
Figure 3.1.shows the recoveries obtained from both milk samples. We can see that 
half of the antibiotics present significantly different recovery in both milk samples. 
Recovery for antibiotics obtained with commercial milk is better. We can say that 
may be the presence of high fat content in raw milk makes the recovery worse than 
commercial milk. From this we can draw a conclusion that to optimize the extraction 
method it is necessary to use the raw milk not the commercial milk.  
 
Figure (3.1) Recovery obtained from raw and commercial milk. 
3.1.2.  Comparison between Air and Nitrogen Drying 
Evaporation step is a critical part of the sample preparation process. A study was 
done comparing (%) recovery of each analyte using commercial milk to see if there 
is difference between the nitrogen and air drying of the sample. 6 samples were 
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prepared at 2 MRL level for each antibiotic and extraction was performed as 
described in section 2.3.2. The elution fraction obtained from SPE was evaporated to 
dryness under a stream of air or nitrogen.  
The recoveries for quinolones and penicillins are similar using two different drying 
techniques. However, the recoveries for cephalosporins are slightly higher with 
nitrogen drying as can be observed in figure 3.2. So nitrogen drying was preferred 
for subsequent studies to be made with raw milk.  
 
Figure (3.2) Recovery (%) obtained for cephalosporin using air and nitrogen drying. 
 
3.2.  Optimization of the Extraction Method  
Three different extraction methods were compared in analysing raw milk to obtain 
maximum recovery. As can be observed in experimental section, table 2.2, methods 
E2 and E3 have a centrifugation step that is made at different points of the sample 
preparation process while E1 do not have their centrifugation step.  
Figure 3.3 show the recovery of the penicillins studied using three different 
extraction methods (E1, E2 and E3).  
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Figure (3.3) Recoveries (%) of penicillins using three different extraction methods 
 
We can see that except for AMOX and AMPI in E2 and E3 the recoveries of 
penicillins are higher than 80 %. 
Figure 3.4 show the recovery of cephalosporins studied using the three methods. As 
can be observed in the figure, the recoveries for cephalosporins are approximately 70 
% except for LEX and QUI.  
 
Figure 3.4 Recoveries (%) of cephalosporins using three different extraction methods 
Figure 3.5 shows the recovery of quinolones using three methods. Quinolones 
present higher recoveries than 60 % except for DAN in method E3.  
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Figure 3.5 Recoveries (%) of quinolones using three different extraction methods 
 
Following conclusions are drawn from the result obtained using three (E1, E2 and 
E3) extraction method.  E1 was not choosen as due to higher amount of fat present in 
raw milk it was difficult to pass the sample through the SPE cartridge without 
centrifugation. E2 and E3 have a centrifugation step. E2 begins with this 
centrifugation step and E3 spike with antibiotics and then centrifuged. Although the 
results of E2 are better than those obtained with E3, the E3 method was choosen for 
subsequent studies because the procedure is more similar to the procedure used for 
positives samples. The E3 method would be given lower results because drugs would 
be lost during the centrifugation step in the same way as positive samples. Thus E3 
was choosen for performing validation study.   
3.3.  UPL C-MS/MS Optimization 
The method that was developed in LC was applied to UPLC. When we change from 
LC to UPLC analysis, the MS parameters need to be altered to obtain the highest MS 
signals. One of the parameters that need to be adjusted is dwell time. Dwell time was 
changed to obtain enough data points for each peak considering that we analyse 21 
antibiotics simultaneously. This parameter measures the period of time that is spend 
collecting data, at a particular mass , and usually ranges 10 ms to 200 ms. Variations 
in dwell time (90 msec, 40 msec, 20 msec and 10 msec) was made with mixture of 
standards. Appropriate dwell time balance the improvement of signal to noise ratio 
with sufficient data points to characterize the chromatographic peaks. With 40ms 
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dwell time the baseline noise is reduced and the peaks are well separated .So 40 ms 
dwell time was selected for carrying out the experimental work. 
3.4.  Comparative Study of Two UPL C Columns 
In order to achieve better separation and retention of analytes, main chromatographic 
condition such as chromatographic column and gradient elution profile was studied 
using two different columns .The column chemistry for two are different as shown in 
experimental section table 2.4 and 2.5 so the separation achieved with two columns 
are different.  
3.4.1. Acquity UPLC B E H shield RP 18 (50 x 2.1 mm, 1.7µm particle diameter) 
Acquity BEH incorporates an embedded polar group (carbamate group) into the 
bonded phase ligand. Features of embedded polar group include alternate selectivity 
to that of alkyl reversed phase columns, excellent peak shape for bases reducing peak 
tailing and aqueous mobile phase compatibility. The organic-inorganic hybrid, with 
ethylsiloxane bridges both on the surface and throughout the body of the material, 
provides a broader range of chemical stability, especially the pH operating range 
(pH1-12), while minimizing interactions of the matrix with any analyte 
functionalities. 
Due to different nature of analytes and in order to elute all analytes in a reasonably 
short time different gradient profile was studied. Initially, the flow was set to 0.20 
ml/min. But the flow rate was small for chromatographic separation so with the same 
gradient condition, flow rate was changed to 0.3 ml/min. The optimized gradient is 
shown in experimental section table 2.4 and figure 3.6 shows the separation. 
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XIC of +MRM (21 pairs): 424,0/292,0 amu from Sample 18 (RE_4MRL_2) of 10_11_09.wiff (Turbo Spray) Max. 1,9e6 cps.
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Figure (3.6) Separations obtained from a milk sample fortified to the 4MRL 
concentration for all antibiotics using Acquity UPLC BEH shield RP 18 column, 
where 1)AMOX, 2) PIR, 3) PIP, 4) QUI, 5) LEX, 6) AMPI, 7) MAR, 8) CIP, 9) 
DAN, 10) LON,11) ENR, 12) ZOL, 13) PER   14) TIO, 15) PIPE 16) PENG, 17) 
FLU,18) OXAC, 19) CLOX, 20) NAFC, and 21) DICL. 
3.4.2. Kinetex 2.6 U C18 (150 x 4.6 mm) 
The Kinetex core-shell particle is not fully porous. Using sol-gel processing 
techniques, a durable, homogenous porous shell is grown on a solid silica core. This 
highly optimized growth process produces an extremely narrow particle size 
distribution and dramatically reduces two major sources of peak dispersion- Eddy 
Diffusion and Resistance to Mass Transfer. This reduces all major sources of band 
broadening that allows for ultra-high performance on any LC system 
Kinetex C18 column was applied in order to obtain the separation for the antibiotics 
studied. The flow rate was changed from 0.3 to 1 ml/min to obtain better separation. 
The best result was obtained with the gradient shown in table 2.4 and the separation 
in Figure 3.7. 
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XIC of +MRM (21 pairs): 424,0/292,0 amu from Sample 11 (RE_4MRL_3) of Kinetex.wiff (Turbo Spray) Max. 1,7e6 cps.
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Figure (3.7) Separations obtained from milk sample fortified to the 4MRL conc. 
using Kinetex column where 1) AMOX, 2) PIR 3) QUI, 4) PIP, 5) AMPI, 6) LEX, 7) 
MAR, 8) LON, 9) CIP, 10) DAN, 11) ENR, 12) ZOL, 13) PER, 14) TIO, 15) PIPE, 
16) PENG, 17) FLU, 18) OXAC, 19) CLOX, 20) NAFC, and 21) DICL. 
 
From the figure 3.6 and 3.7 we can see that the separation of antibiotics with Kinetex 
column is not good because the bands are too broad especially for quinolones. 
Comparatively better results were obtained with the Acquity UPLC BEH RP 18 
column. However desirable, complete separation of the 21 drugs is a secondary 
requirement for multi class multi residue analysis because the quantification and 
identification transition are different for all substances. Moreover the analysis by 
Acquity UPLC column is achieved in less than 3 minutes which is beneficial to be 
applied in routine analytical laboratories as it helps to decrease analysis time and 
solvent consumption.  This column was used for carrying out (%) recovery and for 
analysis of positive samples.  
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3.5. Quality Parameters 
The performance of the developed method was validated according to the European 
Union regulation 2002/657/EC [43] and some parameters from the FDA guidelines 
for bio analytical procedure [44]. The quality parameter established were  
 Limit of detection (LOD),  
 Limit of quantification (LOQ), 
 Linearity (calibration curve),  
 Recovery (%), 
 Precision 
 Decision limit (CCĮ), and  
 Detection capability (CCȕ) 
3.5.1. Limit of detection (LOD) and Limit of quantification (LOQ) 
LOD is the lowest concentration of an analyte that the bioanalytical procedure can 
reliably differentiate from background noise [44] and the limit of quantification 
(LOQ) is the smallest analyte concentration that can be quantified with a given 
confidence level.  
To estimate LOD and LOQ, milk samples were spiked at 8 different concentration 
level ranging from 0.001 to 0.1MRL (0.001, 0.003, 0.005, 0.01, 0.025, 0.05, 0.08, 
and 0.1)                                                   
Limits of detection (LODs) was calculated at a signal to noise ratio of 3 while the 
LOQ value was calculated by using a signal to noise ratio of 10.  
The results obtained for LODs and LODs are shown in table 3.1. 
As can be seen from table 3.1, LODs ranged from 0.03 (NAFC) to 0.5 µg/kg (PER) 
and LOQs from 0.1 (NAFC, PENG, CIP, DAN, and ENR) to 1.25 µg/kg. 
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Table 3.1.L O D and L O Q of antibiotics studied in milk using L C-MS/MS 
 
3.5.2. Linearity and Calibration curve (CC) 
The calibration curve is the relationship between the instrument response and known 
concentration of analyte [43].  
Calibration curves are prepared by plotting the area ratio between the analyte and the 
internal standard versus ratio of analyte concentration and the internal standard 
concentration
   L C-MS/MS 
 Antibiotic M R L L O D (µg/kg) L O Q (µg/kg) 
Penicillins 
AMOX 4 0.1 0.3 
AMPI 4 0.1 0.3 
CLOX 30 < 0.1 0.15 
DICL 30 0.15 0.5 
OXAC 30 < 0.1 0.15 
NAFC 30 0.03 0.1 
PENG 4 0.04 0.1 
Cephalosporins 
LEX 100 0.3 1 
LON 20 0.3 1 
PER 50 0.5 1.25  
PIR 60 0.1 0.3 
QUI 20 0.2 0.5 
TIO 100 0.3 0.5 
ZOL 50 0.15 0.3 
Quinolones 
CIP 100 < 0.1 0.1 
DAN 30 0.03 0.1 
ENR 100 < 0.1 0.1 
FLU 50 0.05 0.15 
MAR 75 0.2 0.5 
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The linearity of the method was evaluated at eight different concentration levels in milk samples. The working range of the curve was from 0.1 to 
3 MRL (0.1, 0.3, 0.5, 1, 1.5, 2, 2.5, and 3 MRL). For each level of concentration two duplicates were prepared. PIPE and PIP was used as 
internal standard for QXLQRORQHVDQGȕ-Lactams respectively at a concentration of 100 mg L-1. 
The samples prepared for calibration curve were analysed using both techniques, LC-MS/MS and UPLC-MS/MS. Table 3.2 summarizes the 
calibration curve using both techniques. 
Using LC-MS/MS, the calibration curves for all analytes are linear in given range with a correlation coefficient of 0.999 with exception of 
AMOX and ENR (0.990).  Although good correlation coefficient was obtained using UPLC-MS/MS, the correlation coefficients are slightly 
lower than LC-MS/MS.  
Table 3.2 Calib ration curve of each studied analyte together with thei r correlation coefficient 
 
Family  Antibiotic L C-MS/MS r UPL C-MS/MS r 
Penicillins 
AMOX y = 0.383x-0.000177 0.990 y= 0.181x+ 0.000478 0.981 
AMPI y = 3.22x-0.00115 0.993 y=1.48x + 0.00342 0.990 
CLOX y = 0.74x-0.00144 0.995 y=0.515x+ 0.00211 0.988 
DICL y = 0.727x-0.0176 0.995 y= 0.341x-0.0166 0.960 
NAFC y = 5.49x+0.00881 0.992 y= 3.54x+0.192 0.985 
OXAC y = 1.38x+0.00807 0.996 y= 0.589x +0.0044 0.990 
PENG y = 1.96x+0.00368 0.995 y= 1.48x+0.00384 0.997 
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Cephalosporins 
LEX y = 0.506x-0.0123 0.995 y=0.16x+0.0106 0.982 
LON y = 0.953x+0.00578 0.994 y=0.769x+0.0179 0.983 
PIR y = 3.09x+0.00693 0.993 y=1.18x+0.142 0.984 
PER y = 0.0262x+0.00196 0.993 y= 0.0103x+0.000619 0.980 
QUI y = 0.431x-0.0033 0.991 y=0.114x -0.00156 0.990 
TIO y = 0.407x+0.00892 0.993 y=0.116x+ 0.0136 0.990 
ZOL y = 0.248x+0.0192 0.990 y=0.212 x+0.0149 0.986 
Quinolones 
CIP y = 1.36x-0.00526 0.992 y=1.36x+ 0.0915 0.986 
DAN y = 0.185x-0.00886 0.991 y=1.1x-0.0701 0.985 
ENR y = 15.2x-1.3 0.990 y= 4.05x-0.0632 0.990 
FLU y = 40x+3.16 0.996 y=3.34x+0.419 0.983 
MAR y = 5.65x-0.569 0.995 y=2.99x-0.189 0.986 
 
Where y * = instrumental response ( A analyte / A IS )  
x * = analyte concentration / IS concentration. 
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3.5.3. Recovery (%) Study 
The accuracy of the method was assessed by recovery test. The recovery of an 
analytical method is defined as the parameter that measures the efficiency that 
method has in the analytes extraction process. Recovery experiments are performed 
by comparing the analytical result of sample in which working standard and internal 
standard are added before the extraction procedure with unextracted standard in 
which samples are spiked with working standard and internal standard after the SPE 
procedure at the same concentration (representing 100 % recovery). 
The recovery (%) is calculated through calibration curve and an external curve. 
- For both calibration and external curve, 8 concentration levels between 0.1 and 
3 MRL were prepared.  
- For the external curve, samples are prepared using the same procedure as for 
calibration samples but the only difference is working solution and internal 
standard are spiked directly to the extracts after the SPE  
- From the external curve equation and the area ratio between antibiotics and 
internal standard obtained in the calibration curves, we have determined the 
recovery of each antibiotic studied.  
 
Table 3.3 shows the recovery for each antibiotic studied using two different 
techniques. The standard error for each recovery is also shown in the same table. 
Using LC-MS/MS, it can be observed that out of 19 drugs analysed 17 drugs 
presented recoveries higher than 65 % with exception of AMOX (57%) and DAN 
(38 %). Using UPLC-MS/MS, recovery (%) is approximately 70 % with exception of 
AMOX (48%), PER (59 %) and DAN (42%).  
Comparing the recoveries obtained from both techniques, it can be observed that 
most of the antibiotics present differences lower than 10 %, except for NAFC, PER, 
QUI and TIO. The significant difference in recovery in these antibiotics may be due 
to some variation in procedure. Before we inject the sample in UPLC-MS/MS, we 
pass the sample through centrifugal filter device (0.22 µm). This may be one of the 
reasons behind low recovery of some analyte. The other reason may be the sample 
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volume was insufficient to be injected into UPLC-MS/MS as same sample that was 
finished analyzing in LC-MS/MS was injected in UPLC-MS/MS.  
Table 3.3 Recovery of Antibiotic studied in M ilk samples using L C-MS/MS and 
UPL C-MS/MS 
  L C-MS/MS UPL C-MS/MS 
Family Antibiotic Recovery (%) Recovery (%) 
Penicillins 
AMOX 57(4) * 48(3)* 
AMPI 78(2) 69(2) 
CLOX 90(2) 99(4) 
DICL 101(2) 100(13) 
NAFC 93(3) 122(7) 
OXAC 86(2) 95(3) 
PENG 78(2) 88(1) 
Cephalosporins 
LEX 83(2) 82(4) 
LON 112(2) 110(4) 
PIR 117(3) 100(5) 
PER 76(3) 59(3) 
QUI 105(3) 94(4) 
TIO 97(3) 77(3) 
ZOL 112(4) 108(5) 
Quinolones 
CIP 67(2) 77(4) 
DAN 38(2) 42(2) 
ENR 69(3) 77(3) 
FLU 106(3) 116(7) 
MAR 86(3) 82(4) 
 
*% Error associated with recovery (Standard error) 
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3.5.4. Precision Study 
The precision of the method was evaluated in terms of repeatability (single day ±
intraday precision) and intermediate precision (different days - interday precision).  
The repeatability of an analytical method is defined as the ability of the method to 
generate the same results in repeated analysis of the same sample, performed by the 
same operator under the working conditions of the equipment. The procedure was 
repeated on 3 different days in order to determine inter-day precision. 
The intra-day and inter-day precision of the methods were evaluated at three 
concentration levels (0.5 MRL, 1 MRL and 2 MRL). 5 replicates were prepared for 
each concentration. To quantify the concentration of samples, calibration curve was 
prepared that was injected along with the samples. Finally, the relative standard 
deviation (%) of the results was calculated. The acceptance criteria for RSD are 15 % 
(except for LOQ 20 %) which is based according to the FDA guidance for validation 
of analytical methods. [44] 
Tables 3.4 and 3.5 shows the values obtained for intra-day and inter-day repeatability 
for antibiotics studied in milk using LC-MS/MS. 
As can be observed from the table 3.4, the repeatability values expressed as RSD % 
are lower than 15 % which is within the acceptance criteria.  Similar results are 
obtained in other two consecutive days.  
 
 
 
 
 
 
 
 
 
 
European Masters in Quality in Analytical Laboratories 
 
 57 
Table 3.4 Intra-day repeatability values for antibiotic studied in milk using L C-
MS/MS. 
 
Family Antibiotic 0.5 M R L (n=5) M R L (n=5) 2 M R L (n=5) 
  Conc. %RSD Conc. % RSD Conc. % RSD 
Penicillins 
AMOX 1.8 3 3.9 3 7.8 2 
AMPI 1.4 10 3.6 8 7.5 7 
CLOX 15.1 1 29.2 3 59.2 2 
DICL 14.9 3 29.9 4 59.4 2 
OXAC 14.3 4 29.0 7 59.9 2 
NAFC 13.3 3 26.6 10 57.3 4 
PENG 1.7 9 3.9 7 7.9 2 
Cephalos
porins 
LEX 45.9 6 85.0 5 167.8 13 
LON 8.1 9 16.7 11 35.4 14 
PER 16.6 7 50.7 9 103.1 14 
PIR 23.5 10 44.8 8 97.9 6 
QUI 9.0 9 16.7 9 35.5 10 
TIO 40.5 8 79.8 7 163.5 2 
ZOL 17.9 13 41.0 11 85.4 11 
Quinolon
es 
      CIP 44.7 11 96.8 4 190.5 6 
DAN 15.0 10 35.6 10 68.1 11 
ENR 43.4 7 101.4 4 188.0 6 
FLU 22.5 11 44.7 11 89.7 6 
MAR 35.2 8 82.2 10 144.6 5 
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Table 3.5 Inter-day repeatability values for antibiotic studied in milk using 
L C/MS/MS 
Family Antibiotic 0.5 M R L(n=15) M R L(n=15) 2 M R L(n=15) 
Conc. % RSD Conc. %RSD Conc. %RSD 
Penicillins 
AMOX 1.6 14 3.8 10 7.2 10 
AMPI 1.5 13 3.8 10 7.1 12 
CLOX 14.6 7 29.0 4 60.1 10 
DICL 15.0 8 29.5 7 59.1 10 
OXAC 14.0 5 30.6 8 59.8 8 
NAFC 12.3 10 27.4 9 53.3 11 
PENG 1.7 12 3.8 6 7.9 7 
Cephalosporin 
LEX 48.6 8 95.2 10 189.2 10 
LON 7.8 11 17.1 13 36.5 14 
PER 22.7 14 47.5 13 96.9 15 
PIR 22.9 13 46.8 13 90.9 10 
QUI 8.6 14 17.3 15 32.0 12 
TIO 39.3 11 86.3 9 158.5 8 
ZOL 19.1 13 42.1 11 92.2 12 
Quinolone 
CIP 45.3 14 99.4 7 200.9 11 
DAN 15.3 14 28.9 14 61.3 13 
ENR 48.6 13 102.5 8 196.5 8 
FLU 23.0 14 46.0 11 94.5 7 
MAR 34.9 10 85.9 14 139.1 12 
 
As can be observed from table 3.5 all the values are within acceptance criteria. 
3.5.5. Decision Limit and Detection Capability 
In accordance with the 2002/657/EC decision, the validation procedure includes the 
determination of CCĮ (Limit of decision) and CCȕ (Capability of detection). This two 
statistical limits allow to evaluate the critical concentration above which the method 
reliably distinguish and quantify a substance taking into account the variability of the 
method and the statistical risk to take a wrong decision [45].  
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3.6.5.1. Decision limit (CCĮ)  
CCĮ is defined as the limit at and above which it can be concluded with an error 
SUREDELOLW\RIĮWKat a sample is non- compliant [43].  
3.6.5.2. Detection capability (CCȕ) 
DeWHFWLRQFDSDELOLW\&&ȕPHDQVWKHVPDOOHVWFRQWHQWRIWKHVXEVWDQFHWKDWPD\EH
GHWHFWHG LGHQWLILHGDQGRUTXDQWLILHG LQD VDPSOHZLWKDQHUURUSUREDELOLW\RIȕ ,Q
the case of substances for which no permitted limit has been established, the 
detection capability is the lowest concentration at which a method is able to detect 
truly contaminated samples with a statistical certainty of 1 ± ȕ ,Q WKH FDVH RI
substances with an established permitted limit (MRL), this means that the detection 
capability is the concentration at which the method is able to detect permitted limit 
concentrations with a statistical certainty of 1 ± ȕ >] as in the case of antibiotics 
studied.  
For the measurement of CCĮ and CCȕ, 20 blank milk samples were spiked at the 
MRL concentration and were analyzed by the corresponding calibration curves.  
CCĮ is calculated as the concentration at the MRL plus 1.64 times the corresponding 
standard deviation. 
 
In a previous work conducted in the research group in tissue of pig, we found that the 
SD &&Į for all the analytes is similar to the SDMRL, so supposing SD &&Į = SDMRL, 
CCȕ parameter could be calculated as  
 
 
Table 3.6 shows the values of CCĮand CCȕobtained using LC-MS/MS. 
 
 
 
C CĮ=C M R L +1.64x SD M R L 
C Cɴ= C CĮ +1.64x SD M R L 
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Table 3.6 C CĮ and C Cȕ obtained from L C-MS/MS 
 
Thus when samples are analysed we can say that samples with values higher than 
CCȕ are non compliant with an error probability of ɴ.  
 
 
 
   L C-MS/MS 
Family  Antibiotic M R L C CĮ (Pg/kg) C Cȕ (Pg/kg) 
Penicillins 
AMOX 4 5.0 6.1 
AMPI 4 4.6 5.3 
CLOX 30 33.8 37.7 
DICL 30 33.5 36.9 
OXAC 30 33.3 36.6 
NAFC 30 33.5 37.0 
PENG 4 4.52 5.04 
Cephalosporins 
LEX 100 109.5 119.0 
LON 20 24.0 28.1 
PER 50 57.3 64.6 
PIR 60 67.2 74.4 
QUI 20 24.5 29.0 
TIO 100 109.5 119.1 
ZOL 50 55.4 60.8 
Quinolones 
CIP 100 111.3 122.6 
DAN 30 38.3 46.6 
ENR 100 112.0 124.1 
FLU 50 58.9 67.7 
MAR 75 90.3 105.5 
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3.6. Applicability of the Method  
6DPSOHVWKDWZHUHWHVWHGSRVLWLYHLQWKHȕ-lactam screening test were obtained from 
ALLIC in four different lots. The effectiveness of the developed method was 
checked by analyzing these samples. The samples were labelled as M126-138, 
M142-156, M157-167, M170-178 and M184, M189, M190. Most part of the samples 
were analysed in duplicate.  
For samples labelled as M126-138, analysis was done using LC-MS/MS and UPLC-
MS/MS. The results are summarized in table 3.7. From a total of 13 samples 
analysed all the samples contain ȕ-lactam. As can be observed in table 3.7 , using 
both techniques , M128, M130, M131, M132, M133, M138 were non compliant as 
the concentration calculated in these samples were higher than CCɴ values obtained. 
The results obtained with both techniques are comparable except for M135 which is 
non compliant with UPLC technique.  
Table 3.7 Results obtained in the analysis of Positive M ilk Samples  
 L C-MS/MS UPL C-MS/MS 
 Positive in 
Concentration  
(µg/kg) 
Positive in 
Concentration 
(µg/kg) 
M126 AMOXa, PERb 1.3(0.1)a,39(4)b AMOXa, PERb  1.1(0.1)a,55(8)b 
M127 AMOXa, PERb 2.0(0.3)a,6.2(3)b AMOXa, PERb 2.2(0.1)a,17(1)b 
M128 PENG 5.9(0.2) PENG 6.9(0.7) 
M129 AMOX 1.2(0.2) AMOX 1.2(0.4) 
M130 AMOX 7(0.2) AMOX 7.1(0.2) 
M131 PENG 19(0.3) PENG 20(0.01) 
M132 PENG 14(0.4) PENG 14(0.1) 
M133 PENG 29(9) PENG 28(2) 
M134 AMOX 3(0.5) AMOX 3.2(0.5) 
M135 AMOX 4.8(0.6) AMOX 6.2(1.8) 
M136 LEX 36(12) LEX 37(18) 
M137 LEX 66(4) LEX 60(13) 
M138 LEX 128(15) LEX 136(41) 
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Figure 3.8 and 3.9 show the chromatograms obtained by LC-MS/MS and UPLC-
MS/MS for positive sample M138 that present a high concentration of LEX.  
 
Figure 3.8 Chromatogram obtained in the analysis of non compliant sample M138 
using LC-QqQ technique. 
 
Figure 3.9 Chromatogram obtained in the analysis of non compliant sample M138 
using UPLC-QqQ technique  
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The results for (M142-M190) are summarised in table 3.8 with the antibiotics present 
in each sample and their concentration. 
Table 3.8 Results obtained in the analysis of Positive M ilk Samples 
 Positive in Concentration (µg/kg) 
M142 AMOX 7.2(1.6) 
M143 AMOX 4.7 
M144 AMOX 46 
M145 CLOXa, LONb 51.5 (0.9) a, 4.4 (0.2)b 
M146 PIR 11.3 (0.7) 
M147 PENG 3.5 (0.4) 
M148 PIR 7.5(0.8) 
M149 AMPIa, DICLb 2.9 (0.3)a , 2.5(0.2)b 
M150 CIPa, ENRb  22.7(0.9) a,11.1b 
M151 CIPa, ENRb 24.1(0.5) a,11.3(0.4)b 
M154 PIR 6.3(0.6) 
M155 PIR 5.6(0.2) 
M156 PIR 8.4(0.6) 
 
M157 PENG 4.1(0.3) 
M158 PIR 8(0.4) 
M159 PENG 1.6 
M160 AMOX 19(4) 
M161 AMOX 10(1) 
M162 AMPIa, DICLb 6(0.02)a 6.2(0.4)b 
M163 AMOXa,PERb 6.5(1.3)a,7.7(0.4)b 
M164 PIR 9.6 
M165 PENG 6.5 
M166 PIR 22.5(0.8) 
M167 PENG 1(0.05) 
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M170 PENG 3.7(0.2) 
M171 PIR 15(2) 
M172 PENG 3.4(0.6) 
M173 PENG 2.7(0.2) 
M174 PENG 3.8(0.2) 
M175 PENG 3.8(0.2) 
M176 PENG 3.5(0.1) 
M177 PENG 5.1(0.1) 
M178 AMOX 1.9(0.4) 
M184 PENG 14.5 
M189 PENG 12.7(1.4) 
M190 AMOX 42.3(4.4) 
 
As can be observed from the table 3.8, all the samples contain at least one antibiotic. 
Sample M142, M144, M145, M160, M161, M162, M163, M165, M177, M184, 
M189 and M190 were non compliant with an error probability of ɴ͕ as the 
concentration calculated in these samples were higher than CCɴ values obtained.  
From the tested samples, M145 and M163 contain one penicillin and one 
cephalosporin (CLOX and LON) which indicates multiple uses of ȕ-lactam. Two 
samples were positive in the quinolones ENR and its metabolite CIP.  
Figures 3.10 and 3.11 shows as an example the chromatogram obtained for positive 
samples by LC-MS/MS, with the corresponding confirmatory chromatogram. 
Figures 3.10 corresponds to a sample of AMOX with very high concentration of 42.3 
µg/kg, and Figures 3.11 contains PENG with concentration of 12.7µg/kg. 
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Figure 3.10 Chromatogram obtained in the analysis of non compliant sample M190 
with AMOX using LC-QqQ technique. 
 
Figure 3.11 Chromatogram obtained in the analysis of non compliant sample M189 
with PENG using LC-QqQ technique 
From the results obtained from table 3.7 and 3.8, we make a conclusion that AMOX 
and PENG are the most common residues found in milk samples. 14 % of samples 
contained AMOX and 16 % contained PENG .Other samples contain AMPI, CLOX 
and LEX. The presences of these residues were quantified and confirmed .Thus the 
results confirms the applicability of the method for the determination of positive 
samples.
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4. Conclusions 
 A multi-class, multi residue method was developed for the simultaneous 
determination of 19 antibiotics regulated by European legislation 2377/90/EC in cow 
milk using LC-MS/MS. The method was optimised and following conclusions are 
drawn.  
1. Ext raction Procedure 
Several studies were conducted to optimize the extraction method. Following 
conclusions were drawn from the studies.  
 Raw milk is preferred over commercial milk for method development.   
 Drying method affects the recovery of some analytes. Different 
recoveries were obtained for cephalosporins using two different 
drying techniques (air drying or nitrogen drying). Better recoveries 
are obtained with nitrogen drying so it was choosen.  
 For extraction of antibiotics from the milk sample it is preferred to 
weigh, spike and centrifuge in order to simulate the procedure that 
happens in positive samples.  
2. Separation of antibiotics:  
 For LC-MS/MS, with the optimized gradient, and using C8 column 
(150 mm x 4.6 mm, 5µm) separation of 19 antibiotics was obtained in 
11 minutes. 
 UPLC-MS/MS technique was applied to separate antibiotics using 
two different columns. It was found that with the use of Acquity 
UPLC BEH shield RP 18 (50 mm x 2.1 mm, 1.7 µm particle 
diameter) ,19 antibiotics can be analysed in less than 3 minutes  
3. Quality Parameters:  
The developed method was validated. Quality parameters proved this method 
to be efficient.  
 LODs ranged from 0.03 (NAFC) to 0.5 µg/kg (PER). 
 LOQs from 0.1 (NAFC, PENG, CIP, DAN, and ENR) to 1.25 µg/kg 
(PER).The LOQs obtained for each antibiotic are much lower than the 
MRLs (regulation 2377/90).  
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 The calibration curves for all analytes are linear with a correlation 
coefficient of 0.999 with exception of AMOX and ENR (0.990).   
 The majority of antibiotics showed recoveries higher than 65 % with 
exception of AMOX (57%) and DAN (38 %). 
 The repeatability values expressed as RSD % are lower than 15 % 
which are in accordance with FDA regulation.  
 
4. Positive Samples: 
The developed method was applied for 49 real samples supplied by ALLIC. 
Among all samples analysed, 37% of the sample was found to be non-
compliant with an error probability of ɴ. AMOX and PENG was the most 
common residue found. 14 % of non compliant sample contained AMOX and 
16 % contained PENG. 
Thus a simple and efficient method was developed and validated for simultaneous 
determination of 19 antibiotics regulated by European legislation in milk samples 
using LC-MS/MS.  
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Appendix 1: A ntibiotic use in E urope 
The current available data on antibiotic use in the EU/EEA Member States collected 
by the European Surveillance of Antimicrobial Consumption (ESAC) project is 
shown in figure 1.It shows antibiotic use measured in Defined Daily Doses (DDD) 
per 1000 inhabitants and per day. Each bar refers to a specific country while the 
different antibiotic classes used in that country. The reported data mainly refer to 
antibiotic use outside hospitals (outpatient use) which accounts for the largest 
proportion of human consumption. However, comparison of data between countries 
report hospital use and outpatient use together. The total outpatient antibiotic use 
ranged from 11.0 DDD per 1000 inhabitants and per day in The Netherlands to 28.6 
DDD per 1000 inhabitants and per day in France. Penicillins were the most 
frequently prescribed antibiotic class in all countries, whereas the proportion of use 
of other antibiotic classes varied among the countries. 
 
Figure (1) Total outpatient antibiotic use in EU/EEA countries 
* Total use, i.e. including inpatients, for Cyprus, Estonia, Greece and Lithuania. 
** 2006 data for Germany, Greece, Iceland and Lithuania; 2005 data for 
*** Reimbursement data, which do not include over the counter sales without 
prescription. Data source: ESAC 2007. 
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 II 
Appendix 2: Usage of Antibiotic in H uman and A nimals 
According to a study by the European Federation of Animal Health (FEDESA), farm 
animals in 1999 consumed 4,700 tonnes (35 percent) of all the antibiotics 
administered in the European Union, while humans consumed 8,500 tonne (65 
percent). Of the antibiotics that were given to animals, 3,900 tonne (29 percent of 
total usage) were administered to help sick animals recover from disease, while 786 
tonnes (6 percent of total usage) were fed to farm animals as growth promoters. The 
survey estimated that the amount of antibiotics used as growth promoters had fallen 
by half since 1997, when animals consumed around 1,600 tonne as feed additives. 
[1] 
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Table 1 : Overview of published use data of several chemical groups of antibiotics for several European countries, presented in metric 
tonnages (t = 1000 kg) and the relative proportion (% of total antibiotic use) per country [2] 
 
 
 
 
 
 
 
 
 
n.s.,not specified 
Reference  
[1]ftp://ftp.fao.org/docrep/fao/009/a0282e/a0282e00.pdf 
[2] Estimating the use of veterinary medicines in the European Union. S.A.E.Kools ; J.F.Moltmann, T.Knacker, Reg.Toxic. and Pharma 50 
(2008) 59±65
Antibiotic group  Denmark  F inland F rance Netherlands Sweden U K 
Aminoglycosides 11.6 (10 %) 0.3(2%) 77(6%) 9(2%) 0.6(4%) 22(5%) 
Amphenicols, Phenicol 0.3 (0.3%) n.s. 5.2 (0.4) n.s. n.s. n.s. 
ȕ-Lactams and cephalosporins 34.5 (30%) 8.7 (62%) 112 (9%) 45 (10%) 9.6 (60%) 63 (13%) 
Macrolides and lincosamides  16 (14%) 0.5 (3.7%) 96 (8%) 24 (5%) 1.1 (7%) 59 (12%) 
Fluoroquinolones and Quinolones  0.4(0.3%) 0.1(0.6%) 20(1.6%) 7(1.5%) 0.2(1%) 1.1(0.2%) 
Sulfonamides and trimethoprim  12.7 (11%) 2.3 (16%) 240 (19%) 93 (21%) 2.9 (18) 77 (16) 
Tetracyclines  30 (26%) 1.3 (8.9%) 638 (50%) 269 (59) 1.3 (8) 243 (51%) 
Other antibiotics  8.4 (7%) 1 (7 %) 82 (6.5%) 6 (1.3%) 0.4 (2) 11 (2.3) 
Totals  114 14.2 1270 453 16.1 476 
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 IV 
Appendix 3: A ntibiotic Resistance in E urope 
E . coli is the most frequent cause of bacteraemia by gram-negative bacteria, as well 
as community and hospital-acquired urinary tract infections. The Europe-wide 
increase of resistance in E. coli to all antibiotic classes under surveillance is 
continuing and the speed by which important antibiotics like fluoroquinolones are 
losing their activity against E. coli is alarming. This trend is highlighted by the shift 
towards red which is evident comparing the maps of 2003 and 2008 (Fig. 1a and 1b). 
 
 
 
(Note: The country colours range from green to dark red according to the frequency 
of resistance). 
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 V 
Staphylococcus aureus, in its methicillin-resistant form (MRSA), is the most 
important cause of antibiotic-resistant healthcare-associated infections worldwide. In 
2008, more countries showed decreasing MRSA proportions, thus the MRSA 
problem seems to have stabilised, or even decreased for most countries. 
Nevertheless, MRSA proportions are still above 25% in one third of countries (Fig. 
2). 
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 VI 
Pseudomonas aeruginosa (P. aeruginosa) is an important cause of infection among 
patients with localised and systemic immune defects. Resistance to carbapenems in 
P. aeruginosa are high all over Europe, as almost three quarters of the countries (23 
of 32) reported more than 10% carbapenems resistance (Fig. 3). In Europe, multi-
drug resistance is the dominant threat posed by invasive P. aeruginosa. 
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 VII 
K lebsiella pneumoniae (K . pneumoniae) is an important cause of urinary and 
respiratory tractinfections, especially in individuals with impaired immune systems, 
such as people with diabetes and hospitalised patients with invasive devices, such as 
urinary catheters and drips. With regard to K. pneumoniae, a high frequency of 
resistance to 3rd generation cephalosporins (Fig. 4), fluoroquinolones and 
aminoglycosides is evident in Central and South-eastern Europe. Many of these 
strains, including the most frequent one, show resistance to all the above mentioned 
antibiotic classes. 
 
 
 
 
 
 
